Cargando…
Inhibition of precursor B cell malignancy progression by toll-like receptor ligand-induced immune responses
Autores principales: | Fidanza, Mario, Seif, Alix E., DeMicco, Amy, Rolf, Nina, Jo, Sumin, Yin, Bu, Li, Yimei, Barrett, David M., Duque-Afonso, Jesus, Cleary, Michael L., Bassing, Craig H., Grupp, Stephan A., Reid, Gregor S.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053846/ https://www.ncbi.nlm.nih.gov/pubmed/27220664 http://dx.doi.org/10.1038/leu.2016.152 |
Ejemplares similares
-
Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations
por: Atre, Tanmaya, et al.
Publicado: (2023) -
Differential Depletion of Bone Marrow Resident B-ALL after Systemic Administration of Endosomal TLR Agonists
por: Jo, Sumin, et al.
Publicado: (2020) -
Conditional Expression of E2A-HLF Induces B-Cell Precursor Death and Myeloproliferative-Like Disease in Knock-In Mice
por: Duque-Afonso, Jesús, et al.
Publicado: (2015) -
Toll-Like Receptors, Their Ligands, and Atherosclerosis
por: Hodgkinson, Conrad P., et al.
Publicado: (2011) -
Endogenous toll-like receptor ligands and their biological significance
por: Yu, Li, et al.
Publicado: (2010)